Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care

26-Nov-2025 / 17:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

AD HOC ANNOUNCEMENT

Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care

Pinneberg, November 26, 2025 – Viromed Medical AG (“Viromed”; ISIN: DE000A3MQR65), confirms market rumors that the company is in advanced talks with a global MedTech company in the field of wound treatment about signing a cooperation agreement. This mainly involves the use of the cold plasma medical device ViroCAP®/OEM to support wound healing.

Viromed will inform shareholders of further developments in an appropriate manner and in accordance with the legal obligations.

Notifying person:
Uwe Perbandt, CEO Viromed Medical AG

Contact Viromed:
E-Mail: kontakt@viromed-medical.de